MENU CATEGORIES

Connect with us

Submit a Tip
MENU CATEGORIES
Posts Tagged with "minouche shafik congressional hearing"

Several controversial events occurring during Columbia President Minouche Shafik’s tenure as Director at the London School of Economics and Political Science have resurfaced amidst the student demonstrations taking place at Columbia. Editor’s warning: Descriptions of sexual misconduct and white supremacy

Read More

On April 17, Columbia President Minouche Shafik, along with two other board trustees and a Task Force on Antisemitism co-chair, testified before Congress to address allegations of antisemitism on campus.

Read More

Same Semester, New President!

What Should Acting President Claire Shipman's Nickname Be?

View Results

Loading ... Loading ...

Recent Comments

Great question about Barnard placing last in the Free Speech Ranking. Perhaps these round table discussions between the administration and (read more)
Student Journalism Roundtable: A Conversation With Barnard Senior Administration
March 24, 2026
It's an excellent point that the whole purpose of slop bowls, at least for busy people, is to make eating (read more)
The “Corporate Slop Bowl”-ification Of Columbia Dining
March 23, 2026
This review filled me with whimsy and reminded me I believe in fairies too. (read more)
Rekindling Childhood Whimsy With The MaMa Project
March 10, 2026

Comment Policy

The purpose of Bwog’s comment section is to facilitate honest and open discussion between members of the Columbia community. We encourage commenters to take advantage of—without abusing—the opportunity to engage in anonymous critical dialogue with other community members. A comment may be moderated if it contains:
  • A slur—defined as a pejorative derogatory phrase—based on ethnicity, race, gender, sexual orientation, ability, or spiritual belief
  • Hate speech
  • Unauthorized use of a person’s identity
  • Personal information about an individual
  • Baseless personal attacks on specific individuals
  • Spam or self-promotion
  • Copyright infringement
  • Libel
  • COVID-19 misinformation